Ursodeoxycholic acid Other names: Ursodiol UDCA

Chemical formula: C₂₄H₄₀O₄  Molecular mass: 392.572 g/mol  PubChem compound: 31401

Active ingredient description

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A05AA02 Ursodeoxycholic acid A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
URSODEOXYCHOLIC ACID Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
URSO 250 / FORTE Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 128-13-2
DrugBank Drug: DB01586
KEGG Drug: D00734
PubChem Compound: 31401
RxNorm Ingredient: 11065
SNOMED-CT Concept: 317791009
Ursodeoxycholic acid (substance)
SNOMED-CT Concept: 41143004
Ursodeoxycholic acid (substance)
UNII Identifier: 724L30Y2QR
URSODIOL

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.